SAN FRANCISCO, July 29, 2026 — UNIT AI, a physical AI company making enterprise-grade automation more accessible for retailers and third-party logistics (3PL) providers, today announced $12 million in funding to accelerate commercial deployments of its modular, AI-powered platform for end-to-end ecommerce fulfillment and returns across North America. The round was co-led by Prologis Ventures, Dynamo Ventures, and Ground Up Ventures, with participation from eGateway Capital, Recursive Ventures, Think + Ventures, ZEP Fund, and Crosscourt.

The financing comes as retailers and 3PLs face mounting pressure to fulfill more frequent e-commerce orders, manage rising return volumes, and improve labor productivity. UNIT’s modular platform helps operators bring enterprise-grade automation into existing fulfillment environments quickly and cost-effectively. The funding will expand deployment capacity, accelerate product innovation, and support continued commercial growth as the company scales across North America.

UNIT’S platform can deploy in as little as 1,000 square feet and deliver ROI in under 12 months. In just 22 months, UNIT is already working with leading retailers and logistics providers, including Barrett, ShipCalm, DaVinci, Carter, as well as global apparel brands. The company also has a growing pipeline of enterprise brands and 3PLs whose fulfillment networks collectively ship billions of inventory units each year.

UNIT was founded by warehouse automation veterans Guy Glass, who previously founded Caja Robotics (acquired by Fives), a leader in goods-to-person warehouse automation, and Avihou Barkay, President of Plus One Robotics and GM of Caja Robotics. After decades of designing and deploying robotic fulfillment systems for global warehouse operators, Glass and Barkay founded UNIT to remove the cost, complexity, and infrastructure barriers that have historically limited automation adoption.

“After decades of building warehouse automation, we realized the next breakthrough wasn’t building bigger systems; it was making automation dramatically more accessible,” said Guy Glass, Founder of Unit AI. “The world’s largest retailers and logistics providers are looking for enterprise-grade automation that can be deployed in a week instead of months. This funding allows us to scale our deployment capacity, accelerate product innovation, and meet that growing demand.”

Today’s fulfillment infrastructure wasn’t built for the realities of modern commerce. E-commerce growth has increased the pressure on retailers to fulfill more frequent orders while managing rising return volumes, labor shortages, and higher shipping costs. At the same time, companies are moving toward more distributed fulfillment strategies, placing inventory closer to customers through regional warehouses, micro-fulfillment centers, and back-of-store operations.

UNIT enables retailers and logistics providers to automate D2C inventory management and returns wherever inventory lives, from traditional distribution centers to regional fulfillment hubs and back-of-store retail operations. Its standardized Physical AI platform provides predictive inventory software to store, retrieve, and manage individual items without requiring companies to redesign existing facilities.

“Retailers and 3PLs need automation that solves real operational pain points — improving throughput, labor productivity and returns management without forcing a full facility redesign,” said Todd Lewis, senior vice president, Prologis Ventures. “UNIT is addressing a clear market need with a modular platform that gives operators flexible automation that can scale and adapt to changing customer demands.”

About UNIT AI

UNIT AI develops Physical AI-powered software that automates each-level inventory management, e-commerce fulfillment, and returns for retailers, brands, and third-party logistics providers. Its modular, pay-per-use platform enables customers to automate fulfillment operations, scale incrementally, and reduce costs while accelerating deployment across their warehouse networks.

Press Contact:
Kathy Osborne
607-434-2065
[email protected]

SOURCE Unit AI

DENVER, July 29, 2026 — SDR Ventures is pleased to announce that Boxzooka (the “Company” or “Boxzooka”), a technology-driven third-party logistics (3PL) and fulfillment partner for premium, high-growth e-commerce brands, has received a majority growth investment from Tower Arch Capital. SDR served as the exclusive sell-side advisor to Boxzooka throughout the transaction process.

Founded in 2014 by Brendan Heegan, Boxzooka is a leading software-driven fulfillment platform built for high-growth, brand-sensitive e-commerce companies. The Company partners with emerging, luxury-oriented apparel, beauty, and wellness brands to deliver highly customizable, high-touch fulfillment solutions that improve order accuracy, brand presentation, and customer experience. Boxzooka’s Fulfillment Platform-as-a-Service (FPaaS) is purpose-built for demanding applications such as complex forward and reverse logistics, premium unboxing, and real-time order visibility, where brand protection and operational precision are essential

“This partnership with Tower Arch Capital is an important next step for Boxzooka,” said Brendan Heegan, Founder & CEO of Boxzooka. “We have a strong platform, a great team, and a reputation for quality and service. We are very excited for this new partnership with Tower Arch and leaning on their expertise in scaling logistics enterprises.  We are grateful to SDR Ventures, Curran & Company, LLP, and Taft Law for their work getting us here.”

Boxzooka has built a differentiated position through proprietary fulfillment technology, close customer relationships, and a consultative approach to complex logistics and brand-experience challenges. The Company’s ability to deliver tailored, high-touch fulfillment at scale, while holding high standards for accuracy, quality, and speed, has made it a trusted partner for premium, high-growth e-commerce brands. That operational discipline and customer focus have driven Boxzooka’s growth.

“Congratulations to Brendan, Nick, and the whole Boxzooka team; they’ve been great to work with throughout this process,” said David Topham, Partner at Tower Arch Capital. “Boxzooka has built something unique: a fulfillment platform that combines proprietary technology with the kind of high-touch, consultative service that complex, brand-sensitive customers need. We’re excited to partner with the entire Boxzooka team and further build on its leadership in software-driven, omni-channel fulfillment.”

“We’re proud to have worked with the Boxzooka team on this transaction and to support a Company with such a strong reputation for technology and customer focus,” said Scott Mitchell, Managing Partner at SDR Ventures. “We believe this partnership with Tower Arch Capital will accelerate software commercialization and create long-term value for Boxzooka’s customers, employees, and stakeholders.

ABOUT SDR Ventures
SDR Ventures is a Denver-based investment bank serving lower-to-middle market business owners across North America. We specialize in sell-side advisory, buy-side representation, exit planning, capital raising, and strategic consulting for privately held companies. Our team works with founders and operators across industries, including manufacturing, distribution, business services, healthcare, technology, food and beverage, agribusiness, industrial, pets, consumer, and data center. The SDR Ventures approach of “Thinking Like Owners” helps businesses maximize their value.

For more information, please visit www.sdrventures.com 

Media Contact: 
Kristy Marshall
SDR Ventures
720-221-9220
[email protected]

SOURCE SDR Ventures

OTTAWA, ON, July 29, 2026 — Woodway Assurance today announced that international healthtech venture capital firm Nina Capital has invested in the Canadian company. The investment reflects growing demand for privacy-enhancing technologies such as Woodway’s EviData^TM, which helps organizations use data responsibly for AI, analytics and data sharing.

Healthcare and life sciences organizations hold large volumes of high-value data, but projects often stall because of uncertainty about whether and how the data can be used safely. Woodway’s flagship software, EviData, offers a single automated, AI-enabled workflow that assesses privacy risk across both structured data and unstructured text, recommends and performs privacy-preserving data transformations, evaluates de-identified, anonymized and synthetic data.      

Importantly, the software produces objective evidence aligned with recognized guidance and international standards, including ISO de-identification standards, anonymization expectations under the GDPR and the HIPAA Expert Determination Method. This helps organizations move initiatives forward, reduce delays and give business, technical, privacy, legal and governance teams a clear basis for defensible decisions.

“Data is essential for research, AI, and improving patient care. However, necessary privacy and regulatory concerns, as well as complex operational challenges, often prevent organizations from leveraging it fully.” said Marta G. Zanchi, founding managing partner at Nina Capital. “We’re investing in Woodway because EviData directly addresses that challenge with an authoritative solution grounded in extensive research, recognized guidance, international standards, and world-renowned expertise in the field. We see tremendous potential for EviData to reduce friction, accelerate clinical innovation, and facilitate the more rapid delivery of promising treatments to patients.”

The investment follows a period of momentum for Woodway, including the launch of EviData 3.0, a growing client base and new strategic partnerships. The capital will support further product development, commercial growth and entry into new international markets.

“Nina Capital’s backing is an important endorsement of our approach to solving one of the biggest barriers to responsible data use,” said Dr. Khaled El Emam, founder and CEO of Woodway Assurance. “Nina Capital’s health data and technology expertise and international network make them a strong partner as we expand globally. Together, we can bring EviData to more organizations that need faster, scalable and defensible ways to leverage data.”

The new financing builds on Woodway’s $1-million CAD seed round, announced in December 2025.

About Woodway Assurance:
Woodway Assurance is the Canadian technology company behind EviData, an automated, AI-enabled platform that helps organizations use data for AI, analytics and data sharing by assessing privacy risk, performing privacy-preserving data transformations and generating objective evidence. Woodway is a spin-off from the Electronic Health Information Laboratory at the CHEO Research Institute, founded and directed by Woodway CEO Dr. Khaled El Emam. The company builds on 20+ years of pioneering research and privacy-enhancing technologies developed by El Emam and the EHIL team. In 2026, EHIL received the Privacy and Human Rights Award from the Global Privacy Assembly, the international forum of data protection authorities, and the human rights organization Access Now.

About Nina Capital:
Nina Capital is an international, specialized venture capital firm investing in healthcare transformation powered by information technology, led by need-driven founders. Focused on pre-seed and seed-stage investments and guided by deep industry experience, Nina Capital supports health technology solutions that drive lasting healthcare impact. Nina Capital’s diverse, multinational, and multidisciplinary team is led by former healthcare technology founders and operators, and combines expertise from numerous healthcare and technology sectors. Since 2019, Nina Capital has invested in over 50 companies across nearly 20 countries, touching the lives of tens of millions of people through healthcare technology innovations.

Media contacts: Woodway Assurance – Anne-Marie Hayden, [email protected]; Nina Capital – Marta G. Zanchi, Ph.D., [email protected]

Coinbase Ventures and Franklin Templeton join as new investors, with follow-on support from Brevan Howard Digital and existing backers, as Soter continues to build specialized insurance products for the digital asset economy.

ABU DHABI, UAE, July 29, 2026 — Soter Insure, a provider of specialized insurance products tailored to the digital asset economy, today announced the first close of its Series B funding round, led by Galaxy Digital, who also led the Series A, with new participation from Coinbase Ventures and Franklin Templeton and follow-on investment from Brevan Howard Digital and other existing backers. A second close is expected to follow in the coming weeks as Soter finalizes participation from additional strategic investors. Final close of the Series B will bring total funding to date of $23.5mm USD and over 500 BTC and 2000 ETH.

Headquartered in Abu Dhabi and operating out of Bermuda, with offices in London, New York and Dubai, Soter Insure was incubated by Further Ventures and WebN Group. The company offers specialized digital asset insurance products for financial institutions, including, Directors & Officers (D&O), Professional Indemnity (PI), Crime, Specie, Slashing and Smart Contract Failure coverage, uniquely denominated in both fiat and native digital assets.

As the digital asset space continues to mature, the lack of adequate insurance products and scarce capacity remains a significant barrier to broader institutional adoption. Soter Insure addresses this gap by offering comprehensive insurance solutions tailored to the unique risks of decentralized technologies, thereby instilling confidence in institutional and retail participants.

The new funding will support the continued expansion of Soter Insure, deepening its underwriting and technology capabilities and scaling operations across key markets.

“Our mission at Soter is to set a new standard for risk management in the digital asset space. Reaching the first close of our Series B – with Galaxy leading again and new partners like Coinbase Ventures and Franklin Templeton joining alongside the continued support of Brevan Howard Digital – is a powerful validation of the platform we are building and the network effect of our strategic capital stack. Special thanks to Galaxy Digital for their vision and leadership in continuing to support us with the ability to provide solutions at institutional scale. With this capital we will accelerate our product roadmap, expand capacity, and extend our global footprint, and we look forward to welcoming further partners at our second close,” said Henson Orser, Founder and CEO of Soter Insure.

Chris Ferraro, President and CIO of Galaxy said: “Insurance remains a key gap to institutional adoption of digital assets, and Soter has built a platform that closes it. We’re proud to lead this round again, and our continued investment reflects the strength of the team and the growing importance of specialized risk solutions for this asset class.”

For more information about Soter Insure, visit soter.insure.

[email protected] 

SOURCE Soter Services North America LLC

The inaugural program connects biotech and medtech startups from Israel and Taiwan with U.S. investors, regulators, mentors and industry partners.

BOSTON, July 29, 2026 — MassChallenge launches Breakthrough Bio, a global program built to give top biotech and medtech startups in-depth access to the U.S. life sciences ecosystem and the commercialization support that has long been out of reach from abroad. The Israel Innovation Authority (IIA) and Taiwan’s Development Center for Biotechnology (DCB) join Breakthrough Bio as its inaugural partners, leading the way for their startup ecosystems.

Innovation in biotech and medtech has gone global. Groundbreaking science and technology are emerging from academic labs, corporate spinouts, and founder-led startups across Israel, Taiwan, and other countries worldwide. What has not kept pace is access. The capital, mentorship, regulatory expertise and industry relationships that turn breakthroughs into products that reach patients and create durable companies remain concentrated in a few ecosystems.

Breakthrough Bio exists to close that gap. With deep roots in the U.S. life sciences ecosystem, MassChallenge gives high-potential startups from Israel and Taiwan a direct, guided path into one of the most critical expansion markets for their growth, helping them form strategic partnerships, secure investment, and accelerate the development and early market entry that turn breakthroughs into scalable companies.

Breakthrough Bio provides a highly personalized commercialization experience tailored to each company’s stage, technology and growth objectives. Participating startups receive curated engagement with U.S. investors, pharmaceutical and healthcare leaders, regulatory experts, talent, mentors and business development partners.

The program kicks off in early January 2027, anchored by ecosystem immersions on the ground in Boston and Cambridge, in San Diego around LSI USA and in Philadelphia around the 2027 BIO International Convention. Between immersions, participants continue with personalized virtual engagement from a curated roster of expert mentors, targeted curriculum and hands-on preparation for each conference and ecosystem visit. At each stop, MassChallenge guides participants through the largest and most influential gatherings in the field and brings the full weight of the U.S. ecosystem to bear on their success.

Applications for the inaugural Israel cohort open July 29 and close at 12:00 p.m. Israel time on August 18, 2026. Eligibility details and the application are available upon logging into the Israel Innovation Authority online portal at https://innovationisrael.org.il/en/calls_for_proposal/pilots-accelerator-biotech-medtech/.

Applications for the Taiwan cohort open September 1, 2026, and close October 16, 2026. Eligibility details and application information will be available through MassChallenge and the Development Center for Biotechnology closer to the opening date.

Cait Brumme, CEO, MassChallenge: “Great science is being created everywhere, but the path to market still is not open to everyone. Breakthrough Bio goes beyond exposure programs to give the best companies from these ecosystems the one-to-one support, regulatory guidance, investor relationships and industry connections that accelerate commercialization faster, so their innovations reach patients here and in their home countries.”

Dror Bin, CEO, Israel Innovation Authority: “Israel is home to a vibrant innovation ecosystem that consistently produces world-class technologies and companies. One of the most important challenges for early-stage startups, however, is transforming technological excellence into commercial success by securing their first strategic customers and partners in global markets. That is where the Israel Innovation Authority plays a critical role in helping promising startups bridge this critical gap by connecting them with the right ecosystems, expertise and opportunities. Breakthrough Bio provides exactly this kind of bridge, enabling Israeli biotech and medtech companies to validate their technologies, forge strategic partnerships and accelerate their path to international growth. By helping more Israeli startups succeed globally, we strengthen both our innovation ecosystem and Israel’s position as a leading hub for science, technology and innovation.”

Tsai-Kun Li, President, Development Center for Biotechnology: “With National Health Insurance and science institutes, exemplified by DCB, based on a public-private partnership, Taiwan has built up one of the most dynamic biotech and medtech ecosystems in Asia, with a growing startup pipeline ready to leap into global markets. It has been a great challenge for many of them to soft-land in the U.S. market. Sustained access to investors, regulatory expertise and industry partners who understand how to translate innovation into commercialization in the U.S. is needed. Breakthrough Bio bonds our efforts and connects Taiwan’s bio-clusters and startups with leading U.S. life sciences hubs. Through our leadership of the BIO HUB at the National Biotechnology Research Park, we bring together resources from industry and government with academic strengths in basic research and clinical medicine to boost young startups. Cooperation with Breakthrough Bio and MassChallenge further opens critical pathways for introducing ‘created in Taiwan’ innovations to the U.S. market. Moreover, enhanced by the Taiwan-Berkeley Health Innovation Accelerator, the joint program driven by Taiwan’s National Development Council and the UC Berkeley School of Public Health, this partnership gives Taiwanese innovations access to complementary networks and commercialization resources across both the East and West Coasts.”

Partnership Inquiries
Government and innovation agencies interested in participating in the 2027-28 Breakthrough Bio program can contact John Valentine, Senior Director of Industry Alliances, at [email protected].

About MassChallenge

MassChallenge is a global institution that backs startups building solutions to complex, systems-critical challenges, working where complexity is high and the path to market is hardest. Founded in Boston, Massachusetts, with offices in Texas, Israel, Switzerland and the UK, MassChallenge connects startups with the partners, programs and capital needed to accelerate commercialization and real-world impact. Since 2009, MassChallenge has supported more than 5,000 startups that have raised over $27 billion in funding. Learn more at masschallenge.org.

SOURCE MassChallenge

FirstMark Capital led the round, with Thomson Reuters Ventures and Y Combinator participating.

NEW YORK, July 29, 2026 — Henry AI Inc. (“Henry”), the AI platform automating back-office knowledge work for commercial real estate teams, today announced a $16.5 million Series A led by FirstMark Capital, with strategic participation from Thomson Reuters Ventures and follow-on investment from Y Combinator, Susa Ventures, 1Sharpe, StoryHouse Ventures, Pioneer Fund, RXR Arden Digital Ventures, Karman Ventures, and Coalition Operators. Adam Nelson, Partner at FirstMark Capital, has also joined Henry’s board of directors.

The raise comes as Henry has established itself as operating infrastructure for the industry’s largest firms. Today, teams from all of the largest commercial real estate brokerages are on the platform, reaching more than 150 firms in total.

Henry automates the document layer that has long functioned as CRE’s most expensive hidden cost: offering memorandums, underwriting, pitch decks, and buyer lists. The platform has produced more than 20,000 client-ready deliverables representing more than $150 billion in underlying deal value. Analyst production time is down 90%, work previously estimated at 15 hours per deliverable now takes about 30 minutes of human review, with a platform-wide median turnaround of under four hours. More than 20% of Henry’s customers have reduced staffing requirements as a direct result.

The customer impact is concrete. At Colliers, EVP Tom de Jong cut broker-opinion-of-value turnaround from three to four days to under two hours. At Cooper Horowitz, a single deal memorandum went from as much as 18 hours to under 15 minutes. At Compass, broker Erich Bubbel cut time per offering package from up to seven hours to about 20 minutes. At Marcus & Millichap, National Retail Group’s Kodi Traver describes the platform as “almost like a second office of agents — a new teammate, but he never sleeps and always gets work done fast.”

Commercial real estate firms sit on decades of proprietary transaction data, including underwriting models, client relationships, deal history, scattered across old files and individual analysts’ heads. That is why Henry has launched Henry Deal, which turns a firm’s entire institutional memory into deliverables across the full lifecycle of a transaction, from underwriting to packaging to close.

“Every deal in commercial real estate is buried under a pile of documents that someone had to make by hand,” said Sammy Greenwall, co-founder and CEO of Henry. “But the documents are just the surface. The real problem is that these firms are sitting on the most valuable data in the industry and can’t actually leverage it. We started by automating the deck. With Henry Deal, we’re shipping the system of record that turns that institutional knowledge into every deliverable a deal needs. Winning the deal today, the entire back office tomorrow.”

“What made Henry impossible to ignore was not just the growth, but the evidence that customers were beginning to treat it as an extension of their team,” said Adam Nelson, Partner at FirstMark Capital. “Henry combines deep commercial real estate expertise with a technical team that is translating that insight into product at remarkable speed. The company began with one of the industry’s most painful back-office bottlenecks; today, it is becoming the system firms rely on to underwrite, win, and execute deals. We believe Henry is on a path to becoming the intelligence layer for commercial real estate.”

Henry will use the new capital to expand its engineering and product teams and build out from a document engine into the system of record for CRE deals. The proceeds fund that expansion, beginning with the June 15 launch of Henry Deal.

“The bottleneck in CRE has never been the data — it’s the cost of turning data into finished deliverables,” said Adam Pratt, co-founder and CTO of Henry. “Every step in the deal chain has been done manually by expensive people under deadline pressure. We built Henry to automate that entire layer. Now we scale it.”

About Henry

Henry is the AI platform automating back-office knowledge work for commercial real estate teams. By replacing manual, high-cost workflows across deal production — from offering memorandums and pitch decks to underwriting packages and transaction summaries — Henry reduces deliverable production time by 90% and helps CRE firms close more deals with fewer resources. Henry is backed by FirstMark Capital, Y Combinator, Thomson Reuters Ventures, Susa Ventures, 1Sharpe, StoryHouse Ventures, Pioneer Fund, RXR Arden Digital Ventures, Karman Ventures, and Coalition Operators. Learn more at henry.ai.

About FirstMark Capital

FirstMark Capital is a New York-based venture capital firm and one of the most active early-stage investors in enterprise technology. Its portfolio includes Shopify, Discord, Pinterest, Miro, and DraftKings. For more information, visit firstmark.com.

Media Contact:

FGS Global
[email protected]

SOURCE Henry AI

Insait IO rebrands as Encore AI and raises $30M Series A to deploy AI agents powered by the company’s patented Interaction Mining technology across every channel

NEW YORK, July 29, 2026 — Encore AI, the first agentic customer interaction platform built to automatically drive more revenue, announced today a $30 million Series A led by Team8,  Planven and The Garage, to expand global deployment of its enterprise AI platform. While most AI agents are designed to deflect calls and reduce the number of customers who ever reach a human agent, Encore AI was built to increase revenue from every customer interaction.

Top sales performers generate disproportionate revenue. They convert more customers, recover more opportunities, and close more deals, but they are scarce. No company can scale its best people across every call, every channel, and every hour. Encore AI removes this ceiling by capturing and replicating the behaviors of top performers. The company partners with leading organizations in the most demanding and regulated industries, including financial services.

Encore AI’s patented Interaction Mining technology studies an organization’s top performers, extracts specific actions that drive results, and deploys them as AI agents. Those agents operate autonomously or alongside live teams, across every channel, in any language, while meeting demanding compliance requirements of the most stringent regulated environments.

“Today’s enterprise AI industry is optimized for cost reduction. Encore was built for the other side of the equation. Every organization already has data showing what its best people do differently. Encore trains AI agents on this data, enabling them to deliver quality and effective customer interactions at scale, resulting in uplift in revenue and satisfaction,” said Dr. Dvir Ginzburg, Encore AI Founder and CEO.

The Series A round was led by Team8, Planven and The Garage, alongside Lukatz and several large commercial banks and insurers that first came on as Encore AI customers and chose to invest after seeing the platform’s impact on their own operations. The Garage, which led the company’s earlier seed round, has backed Encore since its founding.

“Every enterprise is sitting on years of customer interaction data that it is not fully using,” said Hadar Siterman Norris, Partner at Team8. “Encore AI turns that data into revenue by learning what top performers do differently and deploying those behaviors at scale. Just as important, it has built the compliance architecture needed to operate in the most demanding regulated industries. That combination gives Encore the potential to define a new category.”

“The next generation of AI leaders will be defined by the enterprise value they create. We believe vertical AI companies with proprietary data advantages and deep domain expertise will build the enduring platforms of this decade. Encore AI is a compelling example of this vision, transforming years of data into AI that can consistently drive revenue at enterprise scale. We are proud to partner with Dvir and the team as they build what we believe can become a category-defining company,” Eran Westman, Managing Partner at Planven.

“We backed this team from the very beginning, leading both their pre-seed and seed rounds,” said Omer Nagar, Managing Partner, The Garage. “Beyond capital, we worked hand in hand with the founders to validate the product in live banking environments and open doors across our ecosystem. Watching that vision become reality has been rewarding, and we’re as confident today as we were on day one.”

Encore AI can go live in weeks. It does not require months of configuration, testing, and tuning. It builds from a company’s actual operating reality, ingesting calls, chats, emails, and CRM data to rapidly deploy across enterprises. Results are produced rapidly, too: one of Encore AI’s largest lending clients saw a 10x return on investment within months of implementation.

Dr. Ginzburg founded Encore AI in 2022, bringing a background precisely suited to the problem the company solves. His Ph.D. in Geometric Deep Learning and years as a recommendation-systems researcher at Microsoft are the technical lineage behind Encore AI’s patented Interaction Mining technology. His work centered on finding signals in large, complex behavioral datasets, the same challenge Encore now solves at scale.

About Encore AI
Encore AI is the only enterprise agentic AI platform built to generate revenue from complex customer interactions, not deflect them. Using patented Interaction Mining technology, Encore AI deploys AI agents that convert leads, close applications, recover balances, and drive upsell and cross-sell at scale, across voice, chat, IVR, and live form-fill, in even the most regulated environments, including financial services. Encore AI is headquartered in New York with a global presence in APAC and EMEA. Learn more at www.gainencore.ai.

LoBello Communications
[email protected]

SOURCE Encore AI

Expands Enterprise Partnerships with Leading Health Systems

LOS ANGELES, July 29, 2026 — Precise Behavioral, a physician-led behavioral health services and technology company, today announced $14.2 million in venture funding. The round was led by A1 Health Ventures, with participation from Ziegler Link-Age Fund, Converge Capital Partners and Granite Financial Holdings, an affiliate of Blue Cross of Idaho. Already profitable, the investment will help scale the company’s operations, digital SaaS capabilities, and AI roadmap. One of the few companies that can deliver behavioral healthcare both virtually and in-person across multiple care settings and manage the full revenue cycle, this investment follows significant customer growth including expanded partnerships with nationally recognized health systems and academic medical centers.

“As a serial entrepreneur and long-time practicing geriatric psychiatrist who has worked inside of hospitals, emergency rooms and skilled nursing facilities, I have seen firsthand how rising patient demand, workforce shortages and fragmented care are impacting health systems today,” said Nitin Nanda, MD, founder and CEO of Precise Behavioral. “Behavioral health continues to be one of the greatest operational challenges facing hospitals. Service line owners are managing numerous vendors and fragmented workflows when they need a singular enterprise solution that improves access, outcomes, and operational performance. This investment allows us to continue to scale our operating system for the next wave of behavioral health.”

Founded by clinicians and deep healthcare operators, Precise Behavioral partners with hospitals, health systems, ACOs, skilled nursing facilities and correctional facilities to modernize behavioral healthcare delivery through its integrated technology, operational services and clinical programs. One of the few companies that delivers care across Inpatient, Emergency and Ambulatory settings, Precise offers a singular unified platform that replaces the need for multiple, disconnected vendors by offering a modular and fully customizable solution set.

“No one has holistically addressed the behavioral health needs of health systems and hospitals comprehensively. Precise Behavioral targeted this niche early on and has scaled rapidly, reaching profitability in under three years, delivering more than 100,000 patient encounters, and building a national clinical footprint,” said Karim Botros, Managing Partner at A1 Health Ventures. “We believe Precise is uniquely positioned to define this enterprise behavioral health category.”

Leading Health Systems Choose Precise Behavioral
Over the past year, Precise Behavioral has continued to expand its footprint with health systems seeking support across consultation-liaison psychiatry, outpatient behavioral health, collaborative care, digital patient engagement, referral management, and care navigation. The company partners with several leading health systems, including: CommonSpirit and Prime Healthcare. These partnerships reflect growing demand for integrated psychiatric and therapy care models that reduce operational complexity and expand access.

“As patient demand for mental health services continues to increase, there’s never been a more important time for us to expand our offerings to reach more people,” said June Collison, former President of Community Hospital San Bernadino, CommonSpirit. “Precise is one of the few companies that offers a hybrid of in-person and virtual on-demand psychiatric services across inpatient and outpatient settings. They seamlessly integrate high-quality behavioral healthcare services into our healthcare system across the continuum and drive quality measure improvements while increasing patient access to essential services.”

“We invested in Precise Behavioral because its product is uniquely flexible and its leadership is extremely qualified,” said Jenny Poth, SVP at the Ziegler Link-Age Fund. “The company has a plug-and-play platform that supports patients across the continuum of care – from hospital entry, through post-acute care and even into the home. Every module can be combined, expanded or reconfigured, creating a tailored behavioral healthcare solution that integrates seamlessly into any ecosystem. The CEO and founder is a highly experienced physician who has cultivated a team with deep clinical and operational backgrounds. We are confident they will deliver exceptional experiences to their partners and patients.”

Delivering Comprehensive Behavioral Health Care Across All Settings
The company has built the Precise Behavioral Operating System (BOS) which unifies clinical delivery, operational workflows, and revenue cycle management into a single, scalable system. The platform is configurable across care settings and provides on-demand clinical consults, a virtual psychiatry and ambulatory clinic, a post-discharge emergency room follow-up solution and collaborative care to help integrate behavioral health into primary care settings. These four solutions all come with specialized revenue cycle management and billing services that help clients streamline reimbursement and maintain regulatory compliance.

The current round of financing will support the company’s continued enterprise platform growth, including enhancements to AI-powered patient engagement tools, referral management capabilities, virtual care operations and analytics.

About Precise Behavioral
Precise Behavioral is a technology-enabled behavioral health company founded in 2022 by Dr. Nitin Nanda, a geriatric psychiatrist and healthcare entrepreneur who exited his last company (Aligned Telehealth) to Amwell, Inc, a publicly traded telehealth company. Building on that success, Precise Behavioral aligns clinical delivery, operational workflows and reimbursement into a single unified system supported by a nationwide clinical network and AI-enabled technology. It provides behavioral healthcare services and technology solutions to health systems, skilled nursing facilities, ACOs, medical groups and correctional facilities by offering four core out-of-the-box configurable solutions, including: Precise Clinical, a national network of psychiatrists, nurse practitioners, therapists, and care managers providing on-demand and embedded behavioral health coverage in the ED, inpatient, and outpatient settings; Precise Digital Outpatient OS, a virtual psychiatry and ambulatory clinic that supports measurement-based care, patient monitoring, risk scoring, and virtual visits; Precise ConnectED, a post-discharge follow-up application for ED patients that offers virtual care and engagement to reduce repeat visits and support HEDIS measures; and Precise Collaborative Care psychiatric consults, care management, and population tracking for primary and specialty care practices.

For more information or to inquire about partnership opportunities, visit https://precisebehavioral.com.

Media Contact:
Audrey Mann Cronin
(914) 260-9651
[email protected]

SOURCE Precise Behavioral

NEW YORK, SINGAPORE and ABU DHABI, UAE, July 29, 2026 — AIBNKO today announced the official launch of its AI-based, multi-agentic sell-side research platform – the first system of its kind capable of initiating, producing, and distributing institutional-grade equity research entirely without human intervention. The platform can track and cover an unlimited number of global equities in real time – a scale no traditional sell-side desk, constrained by analyst headcount, can match.

Traditional sell-side research has long struggled with three structural bottlenecks: limited coverage capacity, inherent conflicts of interest, and single-analyst subjectivity. AIBNKO’s fully autonomous, multi-agentic workflow removes all three constraints without compromising research quality.

Purpose-built for institutional workflows, AIBNKO is an AI-based, multi-agentic platform that generates comprehensive, deep-dive investment research reports on global equities – on demand. Rather than relying on generic LLM summaries, portfolio managers can now produce institutional-grade analysis in a few minutes – for any stock in any market. The era of digging through static research libraries in search of coverage is over. AIBNKO seamlessly replicates the rigorous methodology of a top-tier analyst team, serving as the investment committee of the new era: faster, smarter, and inherently unbiased.

“For decades, sell-side research has been bottlenecked by headcount and, too often, quietly shaped by incentives that have nothing to do with getting the call right,” said Zvika Fine, Founder of AIBNKO. “We built AIBNKO to remove both problems at once. It doesn’t get tired, it doesn’t play favorites, and it doesn’t skew bullish. When only one in five of your ratings is a Buy, that’s not a platform trying to please anyone – that’s a platform doing its job. This is our moat, and it’s not one anyone can replicate by hiring more analysts. We built this from the ground up to be unbiased, and the industry is going to have to catch up to that standard.”

About AIBNKO

AIBNKO redefines institutional equity research by replacing static models with a dynamic, multi-agentic AI framework that operates with the precision of a high-performance investment committee. By orchestrating specialized AI agents, the platform ensures every recommendation is stress-tested against diverse strategies and rigorous governance standards. This fully independent framework doesn’t just monitor global markets and summarize earnings – it actively learns from its own hits and misses through a closed-loop auditor agent, continuously refining its methodology to deliver unbiased, alpha-generating insights that evolve in real time with the market.

AIBNKO research reports are accessible to qualified investors via leading financial terminals and through its subscription-based platform at aibnko.com.

Media Contact:

Laura Miscolzi

+972-842-0719

[email protected]

SOURCE AIBNKO LTD